Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × vandetanib × Clear all

NCT00566995 2018-10-30

Phase II Study of Vandetanib in Individuals With Kidney Cancer

Phase 2 Completed

37 enrolled 16 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01372813 2015-10-23

Vandetanib to Treat Advanced Kidney Cancer

Phase 2 Terminated

3 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms